R&D Systems™ Recombinant Human EphA1 Fc Chimera Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

The Recombinant Human EphA1 Fc Chimera Protein is derived from HEK293. The Recombinant Human EphA1 Fc Chimera Protein has been validated for the following applications: Bioactivity.

Specifications

• Formulation: Supplied as a 0.2μm filtered solution in MES, NaCl, PEG, CHAPS and Imidazole.
• Gene ID (Entrez): 2041
• Molecular Weight (g/mol): 83.5 kDa (monomer)
• Name: EphA1 Fc Chimera
• Quantity: 100 μg
• Source: Human embryonic kidney cell,HEK293-derived human EphA1 protein, (N-terminus) Human EphA1 (Met1-Glu547) Accession &Num; AAA36747 DIEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after opening. 3 months, -20 to -70° C under sterile conditions after opening.
• Structural Form: Disulfide-linked homodimer
• Conjugate: Unconjugated
• Recombinant: Recombinant
• Purity or Quality Grade: 95%, by SDS-PAGE under reducing conditions and visualized by silver stain.